Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Formation-stimulating regimens other than sodium fluoride

B L Riggs1

  • 1Division of Endocrinology and Metabolism, Mayo Clinic, Rochester, Minnesota 55905.

The American Journal of Medicine
|November 30, 1993
PubMed
Summary

New osteoporosis treatments are in development, including parathyroid hormone fragment (PTH(1-34)) and insulin-like growth factor-I. Future therapies may involve oral medications stimulating bone growth factors, potentially available within five years.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relationship of femoral neck areal bone mineral density to volumetric bone mineral density, bone size, and femoral strength in men and women.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2011
Same author

Determinants of forearm strength in postmenopausal women.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2011
Same author

Trabecular bone deficits among Vietnamese immigrants.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2010
Same author

Assessing forearm fracture risk in postmenopausal women.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2009
Same author

Estrogen action on bone marrow osteoclast lineage cells of postmenopausal women in vivo.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2008
Same author

Comparison of sex steroid measurements in men by immunoassay versus mass spectroscopy and relationships with cortical and trabecular volumetric bone mineral density.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2008

Area of Science:

  • Orthopedics and Regenerative Medicine
  • Pharmacology and Drug Discovery

Background:

  • Established osteoporosis currently lacks approved bone formation-stimulating treatments.
  • Existing therapies primarily focus on slowing bone loss rather than stimulating new bone growth.

Framework:

  • Investigational therapies include parathyroid hormone fragment (PTH(1-34)) and insulin-like growth factor-I.
  • These agents are in various stages of preclinical and clinical development.

Implementation:

  • PTH(1-34) and IGF-I are frontrunners for initial clinical application.
  • Future research focuses on developing orally active agents to enhance local growth factor production by bone cells.

Implications:

  • The development of effective bone formation-stimulating regimens for osteoporosis is anticipated within the next five years.

Related Experiment Videos

  • These advancements promise to revolutionize osteoporosis treatment by promoting bone regeneration.